You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin degludec, insulin aspart drug combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • CamAPS FX using faster insulin aspart
  • CamAPS FX using standard insulin aspart
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Nov 9, 2022

Type 2 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Buenos Aires, Ar-c, Argentina
  • +40 more
Jan 11, 2022

Type 1 Diabetes Trial in Málaga (Toujeo SoloStar, Tresiba, Humalog Kwikpen)

Completed
  • Type 1 Diabetes Mellitus
  • Toujeo SoloStar
  • +4 more
  • Málaga, Spain
    Regional University Hospital of Málaga
Nov 23, 2021

Diabetes, Diabetes, Type 2 Trial in Neuss (Insulin icodec, , insulin degludec)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +2 more
  • Neuss, Germany
    Novo Nordisk Investigational Site
Aug 23, 2021

Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))

Completed
  • Type 2 Diabetes Mellitus
  • Postprandial Hyperglycemia
  • Insulin aspart (Novorapid®)
  • Stockholm, Sweden
    Department of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022

Type 2 Diabetes Trial in Gurgaon (Degludec, Glargine U300)

Completed
  • Type 2 Diabetes
  • Gurgaon, Haryana, India
    Division Of Endocrinology and Diabetes , Medanta The Medicity Ho
Mar 3, 2022

Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)

Recruiting
  • Diabetes
  • INS062 injection
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Feb 8, 2023

Diabetes, Diabetes, Type 2 Trial in Japan (Insulin degludec/liraglutide, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • Insulin degludec
  • Asahikawa-shi, Hokkaido, Japan
  • +37 more
Mar 10, 2021

Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)

Completed
  • Type 1 Diabetes Mellitus
  • Insulin aspart SAR341402
  • Insulin aspart
  • Little Rock, Arkansas
  • +2 more
Apr 21, 2022

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Diabetes Trial (HR011408 injection; NovoRapid®, NovoRapid®;HR011408 injection)

Not yet recruiting
  • Diabetes
  • HR011408 injection; NovoRapid®
  • NovoRapid®；HR011408 injection
  • (no location specified)
Feb 12, 2023

Diabetes, Type 2 Trial in Worldwide (IcoSema, Insulin glargine, insulin aspart)

Recruiting
  • Diabetes Mellitus, Type 2
  • La Jolla, California
  • +100 more
Mar 24, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine, Insulin aspart)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +2 more
  • Concord, California
  • +82 more
Jul 7, 2022

Type 2 Diabetes Trial in Guadalajara (Insulin Degludec, Insulin Glargine)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Insulin Degludec
  • Insulin Glargine
  • Guadalajara, Jalisco, Mexico
    Instituto de Terapeútica Experimental y Clínica. Centro Universi
Sep 25, 2020

Type 2 Diabetes Trial in Graz (Insulin Aspart, Insulin Aspart 30, Insulin Aspart 70)

Completed
Has Results
  • Type 2 Diabetes
  • Insulin Aspart
  • +2 more
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
Jun 9, 2021

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Type 1 Diabetes Trial (Semaglutide weekly injection)

Not yet recruiting
  • Type 1 Diabetes
  • Semaglutide weekly injection
  • (no location specified)
Sep 21, 2023

Healthy Trial in Beijing (insulin degludec/insulin aspart)

Completed
  • Healthy
  • insulin degludec/insulin aspart
  • Beijing, China
    Novo Nordisk Investigational Site
Feb 13, 2020

Diabetes, Critical Illness, Hyperglycemia Trial in Riyadh (Degludec insulin)

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Degludec insulin
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Sep 24, 2023

Diabetes, Type 1 Trial in Santa Barbara, Honolulu (Insulin Degludec, Insulin Glargine, TRESIBA® FLEXTOUCH®)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Degludec
  • +3 more
  • Santa Barbara, California
  • +1 more
Oct 6, 2022

Type 1 Diabetes Trial in Gentofte (Insulin aspart, Fast-acting insulin aspart)

Unknown status
  • Type 1 Diabetes
  • Insulin aspart
  • Fast-acting insulin aspart
  • Gentofte, Denmark
    Steno Diabetes Center Copenhagen
Feb 12, 2021

Looking at How Ryzodeg® Works in People With Type 2 Diabetes in

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Degludec/Insulin Aspart
  • St Leonards, New South Wales, Australia
  • +58 more
Feb 18, 2021

Diabetes, Type 1 Trial in Palo Alto (Fiasp, Novolog)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Palo Alto, California
  • +1 more
Aug 16, 2021

Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)

Recruiting
  • Diabetes Mellitus, Type 2
  • Graz, Austria
    Clinical Trials Unit, Medical University of Graz
Mar 3, 2023

Glycemic Control in Type 1 Diabetes When Switching to Insulin

Active, not recruiting
  • Type 1 Diabetes
  • Insulin Degludec
  • Leuven, Belgium
  • +1 more
Jun 21, 2022